SenesTech (SNES) Institutional Ownership → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free SNES Stock Alerts $0.75 +0.01 (+0.90%) (As of 11:07 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for SenesTech (NASDAQ:SNES)CurrentInstitutional OwnershipPercentage5.19%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$398.86KNumber ofInstitutional Sellers(last 12 months)0 Get SNES Insider Trade Alerts Want to know when executives and insiders are buying or selling SenesTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNES Institutional Buying and Selling by Quarter Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! SenesTech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/23/2024McAdam LLC64,348$44K0.0%N/A1.252% 11/15/2023Armistice Capital LLC70,425$30K0.0%N/A1.940% 5/16/2022First Wilshire Securities Management Inc.580,000$423K0.1%+123.2%4.749% 9/17/2021Virtu Financial LLC47,624$77K0.0%-56.0%0.391% 8/13/2021Renaissance Technologies LLC199,450$321K0.0%N/A1.637% 8/13/2021Geode Capital Management LLC102,602$165K0.0%N/A0.842% 8/11/2021Bank of New York Mellon Corp76,633$123K0.0%+126.4%0.629% 5/19/2021Virtu Financial LLC108,129$179K0.0%N/A0.889% 5/14/2021Dimensional Fund Advisors LP28,313$47K0.0%N/A0.555% 5/13/2021Bank of New York Mellon Corp33,853$56K0.0%N/A0.664% 5/11/2021Sheaff Brock Investment Advisors LLC44,500$74K0.0%N/A0.873% 8/7/2020Virtu Financial LLC13,353$27K0.0%N/A0.393% 4/29/2020Perkins Capital Management Inc.81,875$169K0.2%N/A4.499% (Data available from 1/1/2016 forward) SNES Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNES shares? During the previous two years, the following institutional investors and hedge funds held shares of SenesTech shares: First Wilshire Securities Management Inc. ($423K), and McAdam LLC ($44K), Armistice Capital LLC ($30K).Learn more on SNES's institutional investors. What percentage of SenesTech stock is owned by institutional investors? 5.19% of SenesTech stock is owned by institutional investors. Learn more on SNES's institutional investor holdings. Which institutional investors have been buying SenesTech stock? The following institutional investors have purchased SenesTech stock in the last 24 months: First Wilshire Securities Management Inc. ($320.18K), Armistice Capital LLC ($70.43K), and McAdam LLC ($64.35K). How much institutional buying is happening at SenesTech? Institutional investors have bought a total of 454,953 shares in the last 24 months. This purchase volume represents approximately $1.80M in transactions. Related Companies: Mustang Bio Institutional Ownership Navidea Biopharmaceuticals Institutional Ownership NexImmune Institutional Ownership Cingulate Institutional Ownership Virpax Pharmaceuticals Institutional Ownership Pear Therapeutics Institutional Ownership GeoVax Labs Institutional Ownership Avalon GloboCare Institutional Ownership Data Knights Acquisition Institutional Ownership ZyVersa Therapeutics Institutional Ownership This page (NASDAQ:SNES) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SenesTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
